- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Search trials
Studi clinici sponsorizzati da Fundacion Cancer FUCA
Totale 2862 risultati
-
Fuda Cancer Hospital, GuangzhouCompletatoCancro ai polmoniCina
-
Fuda Cancer Hospital, GuangzhouCompletato
-
Fuda Cancer Hospital, GuangzhouCompletato
-
Fuda Cancer Hospital, GuangzhouCompletatoNeoplasie polmonariCina
-
Fuda Cancer Hospital, GuangzhouCompletatoNeoplasie del fegatoCina
-
Fuda Cancer Hospital, GuangzhouJinan University GuangzhouCompletato
-
Fuda Cancer Hospital, GuangzhouJinan University GuangzhouCompletatoCancro ai polmoniCina
-
Fuda Cancer Hospital, GuangzhouJinan University GuangzhouCompletato
-
Fuda Cancer Hospital, GuangzhouJinan University GuangzhouCompletato
-
Fuda Cancer Hospital, GuangzhouUniversity of MichiganCompletato
-
Fuda Cancer Hospital, GuangzhouJinan University GuangzhouCompletatoMetastasi da tumore maligno del rene (disturbo) | Reazione - Vaccino mistoCina
-
Fuda Cancer Hospital, GuangzhouJinan University GuangzhouCompletato
-
Fuda Cancer Hospital, GuangzhouJinan University GuangzhouCompletatoCancro al fegatoCina
-
Fuda Cancer Hospital, GuangzhouUniversity of MichiganCompletato
-
Fuda Cancer Hospital, GuangzhouUniversity of MichiganCompletato
-
Fuda Cancer Hospital, GuangzhouJinan University GuangzhouCompletato
-
Fuda Cancer Hospital, GuangzhouJinan University GuangzhouCompletato
-
Fuda Cancer Hospital, GuangzhouUniversity of MichiganCompletato
-
Fuda Cancer Hospital, GuangzhouJinan University GuangzhouCompletatoCancro colorettale metastatico | Reazione - Vaccino mistoCina
-
Fuda Cancer Hospital, GuangzhouUniversity of MichiganCompletato
-
Fuda Cancer Hospital, GuangzhouUniversity of MichiganCompletato
-
Fuda Cancer Hospital, GuangzhouUniversity of MichiganCompletato
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletatoTumore al fegato | Prove di trapianto di fegatoCina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletatoCancro alla linguaCina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletatoCancro esofageo metastaticoCina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletatoTumori maligni secondari del fegatoCina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletatoCarcinoma epatico ricorrenteCina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletatoCancro del polmone non a piccole cellule metastaticoCina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletatoCancro faringeo ricorrenteCina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletatoSarcoma dei tessuti molli dell'adulto ricorrenteCina
-
Fuda Cancer Hospital, GuangzhouShengxin Biotechnology Institute, BeijingCompletato
-
Fuda Cancer Hospital, GuangzhouShengxin Biotechnology Institute, BeijingCompletato
-
Fuda Cancer Hospital, GuangzhouShengxin Biotechnology Institute, BeijingCompletato
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletatoTumore solido malignoCina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletatoTumore solido malignoCina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletato
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletatoCancro ovarico ricorrenteCina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletato
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletatoTumore del pancreasCina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletatoCancro a cellule renali metastaticoCina
-
Fuda Cancer Hospital, GuangzhouShengxin Biotechnology Institute, BeijingCompletato
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletatoCancro alla lingua ricorrenteCina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletatoCancro al seno ricorrenteCina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletatoCombinazione di elettroporazione irreversibile e immunoterapia NK per carcinoma pancreatico avanzatoTumore del pancreasCina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletatoCarcinoma polmonare non a piccole cellule ricorrenteCina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletatoCancro laringeo ricorrenteCina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletatoTumore solido malignoCina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletatoCancro del polmone non a piccole cellule metastaticoCina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletatoCancro cervicale ricorrenteCina
-
Fuda Cancer Hospital, GuangzhouShenzhen Hank Bioengineering InstituteCompletatoCancro al seno ricorrenteCina